Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial
書誌事項
- 公開日
- 2015-05
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- https://doi.org/10.15223/policy-017
- https://doi.org/10.15223/policy-037
- https://doi.org/10.15223/policy-012
- https://doi.org/10.15223/policy-029
- https://doi.org/10.15223/policy-004
- DOI
-
- 10.1016/j.urolonc.2015.02.013
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Urologic Oncology: Seminars and Original Investigations
-
Urologic Oncology: Seminars and Original Investigations 33 (5), 204.e25-204.e33, 2015-05
Elsevier BV